Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]        
Product Revenue
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Product Cost of Sales
Cost, Product and Service [Extensible Enumeration] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Gross Income
Administrative Expenses 1,554,244 1,428,795 4,296,119 4,020,435
Research and Development Expenses 1,803,232 2,979,408 6,596,942 6,018,565
Interest Expense and Debt Discount 701,090
Stock Based Compensation 352,417 581,663 15,036,051
Loss from Operations (3,709,893) (4,408,203) (11,474,724) (25,776,141)
Other (Income)/Expenses        
Interest and Dividend Income (15,453) (1,714) (21,559) (7,355)
(Gain)/Loss on Sale of Marketable Securities 1,200 1,650 4,849 (39,797)
Unrealized (Gain)/Loss on Marketable Securities (1,899) 298 (1,754) 41,745
Loss on Currency Conversions 758 758
Gain on Debt Forgiveness (180,257)
Uninsured Casualty Loss 1,058,086 (4,442) 1,058,086
Total Other (Income)/Expense (16,152) 1,059,078 (22,906) 873,180
Loss Before Income Tax (3,693,741) (5,467,281) (11,451,818) (26,649,321)
Income Tax Benefit
Net Loss $ (3,693,741) $ (5,467,281) $ (11,451,818) $ (26,649,321)
Basic and Diluted loss per common share $ (0.09) $ (0.15) $ (0.30) $ (0.78)
Weighted average basic and diluted common shares outstanding 39,046,852 37,634,747 38,502,163 34,064,914